Henlius has a proven track record of initiating strategic commercialisation collaborations with global leading pharmaceutical companies in advance of product approvals, which Henlius believes will enable it to expeditiously capture global market share through the established capabilities and resources of partners. To this end, Henlius has entered into license and commercialisation agreements with multiple partners, including Accord Healthcare, Cipla, Biosidus, Jacobson Medical, KG Bio, FARMA DE COLOMBIA, Mabxience etc. Henlius has established its presence in mainstream and emerging markets. 

Contact us: BD@henlius.com